Related Experiment Videos
Diuretic therapy and the risk for renal cell carcinoma
R E Schmieder1, C Delles, F H Messerli
1Department of Medicine/Nephrology, University of Erlangen-Nürnberg, Germany. roland.schmieder@rzmail.uni-erlangen.de
Abstract:
Diuretics are important drugs in the treatment of arterial hypertension, congestive heart failure, the nephrotic syndrome, and other clinical conditions. With diuretic treatment, reduction of both morbidity and mortality has been clearly shown in those conditions. However, a recent meta-analysis showed an increased risk for renal cell carcinoma in patients treated with diuretics. We summarize and critically review data from studies examining the association between diuretic use and renal cell carcinoma. In general, in many clinical conditions, the reduction of mortality with diuretic therapy outweighs a potential risk of renal cell carcinoma. However, in certain conditions, alternative medical treatment should be considered.
Insights
Diuretics effectively treat heart failure and hypertension, reducing mortality. However, some studies suggest a potential increased risk of renal cell carcinoma with their use, warranting careful consideration.
Area of Science:
- Nephrology
- Cardiology
- Oncology
Background:
- Diuretics are crucial for managing arterial hypertension, congestive heart failure, and nephrotic syndrome.
- Established benefits include significant reductions in morbidity and mortality for these conditions.
- Emerging evidence suggests a possible link between diuretic use and an increased risk of renal cell carcinoma.
Purpose of the Study:
- To critically review existing data on the association between diuretic use and renal cell carcinoma.
- To evaluate the overall risk-benefit profile of diuretic therapy in light of potential oncological concerns.
Main Methods:
- Systematic review and meta-analysis of relevant studies.
- Critical appraisal of data examining diuretic use and renal cell carcinoma incidence.
Main Results:
- Diuretic therapy demonstrates clear benefits in reducing morbidity and mortality in various clinical conditions.
- A meta-analysis indicated a potential increased risk for renal cell carcinoma in patients using diuretics.
- The overall reduction in mortality from treated conditions generally outweighs the potential renal cell carcinoma risk.
Conclusions:
- While diuretics offer significant survival benefits, the potential association with renal cell carcinoma requires attention.
- In specific clinical scenarios, alternative treatment options to diuretics may be considered.
- Further research is needed to fully elucidate the relationship between diuretic use and renal cell carcinoma.